Forward P/S Multiple: Enovis (ENOV)

Enovis Corporation - graphic logo of issuer ENOV

The volatility visible on the forward price-to-sales chart for Enovis Corporation (ENOV) is driven by the specifics of the DonJoy brand and implant patents. Stability is provided by management's M&A strategy and the implementation of CNC machines with robotic polishers. The value 0.70 shows the current metric value, allowing the investor to promptly recognize a trend reversal and assess the risks of overpaying for the asset.

enovis.com - ENOV Market Cap to Projected Revenue (period 04/28/2023 - 11/17/2026)

Summary analytical data breakdowns for Enovis Corporation (ENOV)

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Fundamental company analysis:ENOV (DJO Global)
Product sample of Enovis Inc.

Enovis Corporation (ENOV) specifics regarding endoprosthesis production and brand integration are reflected in the company's forward P/S dynamics. This ratio determines the business value relative to expected sales volume, demonstrating the market valuation of future revenue. The calculation allows for the identification of asset overbought conditions or hidden insider accumulation. A low multiplier level confirms capitalization stability even amidst metal supply volatility.

Who Enovis Corporation competes with

Forward P/S Multiple BSX (bostonscientific.com)|EW: Market Cap to Projected Revenue|ResMed - Forward P/S Multiple|Market Cap to Future Revenue Ratio Insulet Corporation|ZBH: Forward P/S Multiple|COO - Market Cap to Expected Sales Ratio|ALGN (Align Corp) - Forward P/S Multiple|Globus Medical Corp (GMED) - Market Cap to Expected Sales Ratio|Forward P/S Multiple TMDX|Forward Price-to-Revenue Multiple Alphatec Holdings, Inc. ATEC|Forward P/S Multiple AORT (artivion.com)|Forward P/S Multiple Integra LifeSciences Corp IART|ESTA - Price-to-Projected Revenue Ratio|BBNX: Price-to-Projected Revenue Ratio|IRMD (IRADIMED CORPORATION) - Forward Price-to-Revenue Multiple|Embecta Corp. - Forward Price to Sales|TNDM (Tandem Corp) - Forward P/S Multiple|Market Cap to Future Revenue Ratio AxoGen Inc AXGN|Price-to-Projected Revenue Ratio SI-BONE Inc (SIBN)|Orthofix Medical Inc. (OFIX) - Projected Price to Revenue|Forward P/S Multiple BVS (bioventus.com)|Forward P/S Multiple OrthoPediatrics Inc. KIDS|Treace Medical Concepts Inc - Forward P/S Multiple|Market Cap to Expected Sales Ratio Blade Air Mobility SRTA|Carlsmed (CARL) - Price-to-Projected Revenue Ratio|Future Price to Revenue RXST (RxSight Ophthalmic)|Price-to-Projected Revenue Ratio clearpointneuro.com|Forward Price-to-Revenue Multiple Stereotaxis, Inc. (STXS)|Forward P/S Multiple STIM|SGHT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Orchestra BioMed, Inc. OBIO|ANIK: Market Cap to Projected Revenue|NSPR: Forward Price-to-Revenue Multiple|Jin Medical - Price to Expected Revenue Ratio|VANI (Vivani Medical Inc) - Forward Price-to-Revenue Multiple|Market Cap to Projected Revenue XTNT|NMTC (n1mtc.com) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Modular Medical MODD|Price-to-Projected Revenue Ratio myomo.com (MYO)|Price-to-Projected Revenue Ratio COCH (envoymedical.com)|Price-to-Projected Revenue Ratio Vivos Therapeutics Inc VVOS|enVVeno Medical Corp. - Price-to-Projected Revenue Ratio|SINT: Forward Price-to-Revenue Multiple|TNON (Tenon Medical, Inc.) - Market Cap to Projected Revenue|Lifeward Ltd. (LFWD) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Autonomix (AMIX)|Price-to-Projected Revenue Ratio INVO Fertility|Bone Biologics Corp. (BBLG) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple AXNX (Axonics Modulation Technologies)|BIOL (Biolase, Inc.) - Forward Price to Sales|Forward P/S Multiple DYNT (dynatronics.com)|Forward Price to Sales FNA|INVO Bioscience - Forward P/S Multiple